- Home
- U.S.
- World
- Business
- Markets
- Tech
- Personal Finance
- Life & Style
- Opinion
- Careers
- Real Estate
- Small Business
- Asia
- Europe
- Earnings
- Economy
- Health
- Law
- Autos
- Management
- Media & Marketing
-
More Industries
- Accounting
- Advertising
- Airlines
- Banking
- Chemicals
- Computer Hardware
- Computer Software
- Consumer Products
- Defense & Aerospace
- Energy
- Broadcasting & Entertainment
- Financial Services & Insurance
- Food & Tobacco
- Hospitality
- Industrial Goods & Services
- Marketing & Strategy
- Media Agencies
- Metals & Mining
- Paper & Forest Products
- Pharmaceutical & Biotech
- Real Estate
- Retail
- Semiconductors
- Transportation
- Utilities
- Columns & Blogs
-
Health-Care Outlays Climb Slowly
U.S. health-care spending in 2007 grew at its slowest pace in nearly a decade but still rose faster than GDP or wages. Restrained by a sharply slower growth in prescription-drug spending, the nation's health-care tab grew 6.1% to $2.2 trillion, or $7,421 a person.
-
![[Apple CEO Steve Jobs]](http://s.wsj.net/public/resources/images/OB-CX202_stevej_A_20090105125024.jpg)
Apple's Jobs Under Treatment to Gain Weight
Steve Jobs disclosed that a "hormone imbalance" has been causing him to lose weight. The health of the Apple CEO has been a major concern among investors over the past year.
-
Subscriber Content Read Preview
Cigna to Cut 1,100 Jobs
Cigna is cutting 1,100 jobs, or 4% of work force, in light of investment losses and a tight market for health plans.
-
Subscriber Content Read Preview
Daiichi Writes Down Ranbaxy Deal
Daiichi Sankyo is taking a $3.84 billion write-down on its 63.9% holding in Ranbaxy Laboratories of India.
-
Subscriber Content Read Preview
U.S. Drug Approvals Increase
The FDA approved 24 new drugs in 2008, a higher number than in any of the prior three years.
-
Subscriber Content Read Preview
Pfizer Project Looks at Side Effects
Pfizer is joining with two hospitals to test whether computerized patient records can be used in helping regulators detect dangerous drug side effects.
-
Subscriber Content Read Preview
FDA Recalls Eye-Surgery Device
Federal regulators are recalling a surgical device made by Advanced Medical Optics Inc. after receiving reports the product caused inflammation in patients' eyes.
-
New Laws Call for Fire-Safe Cigarettes
Laws mandating stores only sell cigarettes that are slow-burning and fire-safe went into effect in Delaware, Iowa, Oklahoma, Pennsylvania and Texas.
-
Subscriber Content Read Preview
![[eli lilly]](http://s.wsj.net/public/resources/images/OB-CU534_lilly1_A_20081211103054.jpg)
Blood Thinner Finally Gets Hearing
Eli Lilly may soon receive a decision from regulators on blood-thinning drug prasugrel after heart doctors were asked to help review it.
-
Subscriber Content Read Preview
New Hope for Kidney Transplants
A new product from Lifeline Scientific has been shown to make transplanted kidneys less likely to fail, which could help increase the supply of the organ.
-
![[FDA Considers Updating Plavix Label]](http://s.wsj.net/public/resources/images/OB-CW785_plavix_A_20081231085627.jpg)
FDA Considers Updating Plavix Label
The FDA is considering updating the label for anticlotting drug Plavix to include data on genetic factors that could interfere with the medicine.
-
![[Guilty Plea in Tainted-Milk Case]](http://s.wsj.net/public/resources/images/NA-AV041_CMILK_A_20090101195638.jpg)
Guilty Plea in Tainted-Milk Case
Families of children sickened or killed in China's tainted-milk scandal reacted angrily to reports that a former top dairy-company executive admitted in court she knew of the problem months before alerting authorities.
-
Subscriber Content Read Preview
Novartis Plans to Avoid Sales Drop
Novartis is pulling out all the stops to avoid a potential nosedive in sales after the patent of its blood-pressure pill, Diovan, expires in four years.
-
Subscriber Content Read Preview
Drug Researcher Agrees to Curb Role
Joseph Biederman, a top researcher on the use of psychiatric drugs in children, agreed to stop participating in several industry-funded drug trials amid possible conflicts of interest.
-
Subscriber Content Read Preview
Bayer Sues Abbott Over Humira
Bayer filed a patent-infringement lawsuit in federal court against Abbott Laboratories relating to the autoimmune drug Humira, which is Abbott's top-selling product.
Health Blog
-
Pharmalot, R.I.P.; Long Live, Ed Silverman.
The Newark Star-Ledger's trailblazing drug-industry blog is history. Ed Silverman, the man behind the blog, is moving to Elsevier.
-
Merck Seeks FDA Approval for Gardasil in Boys
An expansion of use may spur further questions about the cost-effectiveness of the Gardasil vaccine.
-
Steve Jobs’s Health: What the Pancreas Has to Do With Weight Loss
Steve Jobs's health history suggests his weight loss may stem from lingering problems in his pancreas, after a tumor was removed in 2004.
-
Apple’s Jobs Says Weight Loss Caused by ‘Hormone Imbalance’
He adds that the remedy is relatively simple, and he's already begun treatment.
- Canadians Worry U.S. Health Reform Could Lead to Doctor Poaching
-
See All
RSS Feed
-
Subscriber Content Read Preview
![[grocery labels]](http://s.wsj.net/public/resources/images/MK-AT704_LABELS_A_20090101202432.jpg)
Grocers Launch Labels to Identify Healthy Foods
As obesity and diabetes problems have become more serious, supermarkets hope that consumers will look toward supermarkets to help them balance their diet.
-
Series: Nonprofit Hospitals
-
![[Hospital Struggles to Fulfill Mission]](http://s.wsj.net/public/resources/images/OB-CU631_1211go_A_20081211150720.jpg)
Hospital Struggles to Fulfill Mission
While a number of nonprofit hospitals have grown into profit machines, some, like Mount Sinai in Chicago, have stuck to their charitable mission but struggled financially.
More in the series:
Latest Health Headlines
-
Cigna To Cut 1,100 Jobs, Consolidate Locations
-
IPO Scorecard: Update On Selected Initial Stock Offerings
-
Year-End Data Suggests Health Sector Affected By Recession
-
Gentiva Health Svcs Cut To Mkt Perform From Outperform By Raymond James >GTIV
-
Korian Cut To Sell From Neutral By Goldman Sachs
-
IPO Scorecard: Update On Selected Initial Stock Offerings
-
LHC Group Shares Fall After Deutsche Bank Rating Downgrade
-
Medcath Cut To Hold From Buy By Deutsche Bank >MDTH
-
LHC Group Cut To Hold From Buy By Deutsche Bank >LHCG
-
2nd UPDATE: Akorn Shrs Surge On FDA Drug Approvals >AKRX
-
More Headlines »
Columns
-
Health journal
By Melinda Beck
Diet Books for the New Year
-
Science journal
By Robert Lee Hotz
Warming Earth Blows Hot, Cold and Chaotic
-
The informed patient
By Laura Landro
Health Books You'll Want to Read
-
The doctor's office
By Benjamin Brewer, M.D.
Drop the Excuses; Get a Flu Shot
-
Healthy consumer
By Anna Wilde Mathews
Surprise Health Bills Make People See Red
-
What's your workout?
By Jen Murphy
Executive Lives at the Gym in Two States
More Industries
Subscriber Content
-
Accounting
-
Advertising
-
Airlines
-
Autos
-
Banking
-
Chemicals
-
Computer Hardware
-
Computer Software
-
Consumer Products
-
Defense & Aerospace
-
Energy
-
Entertainment
-
Financial Services & Insurance
-
Food & Tobacco
-
Health
-
Hospitality
-
Industrial Goods & Services
-
Internet & Online
-
Law
-
Marketing & Strategy
-
Media
-
Media & Marketing
-
Metals & Mining
-
Paper & Forest Products
-
Pharmaceutical & Biotech
-
Real Estate
-
Retailing
-
Semiconductors
-
Telecommunications
-
Transportation
-
Utilities
-
![[Alien Hands and Other Medical Oddities]](http://s.wsj.net/public/resources/images/EK-AE398_HEALTH_A_20081229145915.jpg)
Alien Hands and Other Medical Oddities
At the heart of the film "The Curious Case of Benjamin Button" is the invented reverse-aging phenomenon. A look at unusual ailments that are quite real.
-
Subscriber Content Read Preview
A Cardiac Surgeon Pours
Spirit Into Artificial HeartChisato Nojiri, a cardiac surgeon turned chief medical officer of Terumo Heart, has been leading an international team to develop the world's first artificial heart-assisting device using magnetic-levitation technology for the impeller.
-
Spinal Surgery to Get on Your Feet Faster
Physicians say a new minimally invasive spinal surgery trims recovery times but believe more research is needed on its efficacy.
-
The Touch That Doesn't Heal
Americans pay billions for complementary and alternative medicine -- with nothing to show for it.
-
![[Why Every Week of Pregnancy Counts]](http://s.wsj.net/public/resources/images/EK-AE386_HEALTH_A_20081222155939.jpg)
Why Every Week of Pregnancy Counts
New research shows that the last weeks of pregnancy are more important than once thought for development.
Research Health
View an interactive map that shows you how stocks in the Healthcare sector are doing today, at a glance.
Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.
Ask a Question
Ask a question about anything you choose, and let readers from the Journal Community answer it.
- *Required
Email Newsletters and Alerts
The latest news and analysis delivered to your in-box. Check the boxes below to sign up.
- New! To sign up for Keyword or Symbol Alerts click here.
- To view or change all of your email settings, visit the Email Setup Center.
Partner Center
An Advertising FeatureInside the Wall Street Journal Digital Network
MarketWatch
Barron's
All Things Digital
- Overnight Success Takes a Long Time [Voices]
- Time Spent Watching Video Jumps 40 Percent in One Year [Voices]
- Updated: Twitter Security Collapses; Obama, Fox and Britney Accounts Hacked [Voices]
- Used Game Prices Tank as the Market Rewards Big Hits [Voices]
- Is There Some Plum, Oops, I Mean Apple Event Today in San Francisco? [BoomTown]
SmartMoney
-
back to top
-
Help & Information Center:
-
About:
-
WSJ.com:
-
Tools & Formats:
-
Digital Network- WSJ.com
- Marketwatch.com
- Barrons.com
- AllThingsD.com
- FiLife.com
- BigCharts.com
- Virtual Stock Exchange
- WSJ Asia
- WSJ Europe
Foreign language editions:
- WSJ Chinese
- WSJ Portuguese
- WSJ Spanish
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)